Procept Biorobotics Corp Market Cap ($1.13 Billion)
Market Cap & Net Worth: Procept Biorobotics Corp (PRCT)
Procept Biorobotics Corp market cap. Procept Biorobotics Corp (NASDAQ:PRCT) has a market capitalization of $1.13 Billion ($1.13 Billion) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8092 globally and #2419 in its home market, demonstrating a 1.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procept Biorobotics Corp's stock price $20.17 by its total outstanding shares 55878589 (55.88 Million). Also see cash flow conversion of Procept Biorobotics Corp for how efficiently the company converts equity into cash flow.
Procept Biorobotics Corp Market Cap History (2021–2026)
Procept Biorobotics Corp market cap history from 2021 to 2026. Data shows change from $1.40 Billion to $1.13 Billion (-13.28% CAGR). Check latest Procept Biorobotics Corp stock price today for real-time trading data and today's change.
Index Memberships
Procept Biorobotics Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.04% | #238 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #895 of 3165 |
Weight: Procept Biorobotics Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Procept Biorobotics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Procept Biorobotics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Procept Biorobotics Corp to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
20.04x
Procept Biorobotics Corp's market cap is 20.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.40 Billion | $34.47 Million | -$59.85 Million | 40.54x | N/A |
| 2022 | $2.32 Billion | $75.01 Million | -$87.15 Million | 30.94x | N/A |
| 2023 | $2.34 Billion | $136.19 Million | -$105.90 Million | 17.20x | N/A |
| 2024 | $4.50 Billion | $224.50 Million | -$91.41 Million | 20.04x | N/A |
Competitor Companies of PRCT by Market Capitalization
Companies near Procept Biorobotics Corp in the global market cap rankings as of November 5, 2026. Also see Procept Biorobotics Corp assets under control for a full breakdown of the balance sheet.
Key companies related to Procept Biorobotics Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Procept Biorobotics Corp (2021–2026)
Market capitalization of Procept Biorobotics Corp from 2021 to today. Between 2021 and today, Procept Biorobotics Corp's market cap moved from $1.40 Billion to $ 1.13 Billion, with a yearly change of -13.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.13 Billion | -35.89% |
| 2025 | $1.76 Billion | -60.93% |
| 2024 | $4.50 Billion | +92.13% |
| 2023 | $2.34 Billion | +0.89% |
| 2022 | $2.32 Billion | +66.09% |
| 2021 | $1.40 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Procept Biorobotics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.13 Billion USD |
| MoneyControl | $1.13 Billion USD |
| MarketWatch | $1.13 Billion USD |
| marketcap.company | $1.13 Billion USD |
| Reuters | $1.13 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more